Peter Yang

Social SciencesBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis”.

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Scientific Reports(2020)10.1038/s41598-020-73466-6

N/A

0DataRank · unranked

4 citations

Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin Etemad, Seema Nagpal +28 more

Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2072

N/A

0DataRank · unranked

2 citations

Peter Yang, Sam Rubinstein, Martin W. Schoen, Ali Raza Khaki, Jeremy L. Warner +1 more

Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2071

N/A

0DataRank · unranked

2 citations

Aakash Desai, Martin W. Schoen, Bishal Gyawali, Eddy J. Chen, Peter Yang +2 more